MiniMed (MMED) Liabilities and Shareholders Equity (2025 - 2026)
MiniMed (MMED) posted Liabilities and Shareholders Equity of $4.6 billion for Q2 2026, up 6.61% on a QoQ basis from $4.3 billion in Q1 2026, and up 10.21% year-over-year from $4.2 billion in Q2 2025.
MiniMed (MMED) Liabilities and Shareholders Equity (2025 - 2026) Analysis & Trends
MiniMed's Liabilities and Shareholders Equity history runs 2 years deep, the most recent figure standing at $4.6 billion for Q2 2026.
- Quarterly Liabilities and Shareholders Equity rose 10.21% year-over-year to $4.6 billion in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $13.2 billion (changed N/A YoY) and the FY2026 annual result came in at $4.6 billion, up 10.21% from the prior year.
- Liabilities and Shareholders Equity was $4.6 billion for Q2 2026 at MiniMed, up from $4.3 billion in the prior quarter.
- Across five years, Liabilities and Shareholders Equity topped out at $4.6 billion in Q2 2026 and bottomed at $4.2 billion in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 31.90 Bn | 24.59 Bn | 662.02 Mn | 9.13 Bn |
| 2 | BrightSpring Health Services | 14.63 Bn | 13.73 Bn | 482.22 Mn | 6.21 Bn |
| 3 | Healthequity | 8.31 Bn | 8.04 Bn | 256.31 Mn | 3.31 Bn |
| 4 | Hinge Health | 5.95 Bn | 5.64 Bn | 154.23 Mn | 728.77 Mn |
| 5 | 10x Genomics | 5.84 Bn | 5.30 Bn | 106.18 Mn | 1.02 Bn |
| 6 | Waystar Holding | 4.49 Bn | 4.42 Bn | 216.84 Mn | 5.84 Bn |
| 7 | MiniMed | 4.47 Bn | 4.17 Bn | 480.00 Mn | 4.63 Bn |
| 8 | Doximity | 3.96 Bn | 3.22 Bn | 125.97 Mn | 1.12 Bn |
| 9 | Privia Health | 3.18 Bn | 2.76 Bn | - | 1.42 Bn |
| 10 | Omnicell | 1.86 Bn | 1.62 Bn | 140.36 Mn | 2.00 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 24, 2026 | 4.63 Bn |
| Jan 23, 2026 | 4.34 Bn |
| Apr 25, 2025 | 4.20 Bn |